<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ900913-0134</DOCNO><DOCID>900913-0134.</DOCID><HL>   OTC Focus:   Market Is Higher on Egyptian Report   Of Movement to Overthrow Iraqi Leader   ----   By Anne Newman   Staff Reporter of The Wall Street Journal</HL><DATE>09/13/90</DATE><SO>WALL STREET JOURNAL (J), PAGE C6</SO><IN>STOCK MARKET, OFFERINGS (STK)STOCK INDEXES (NDX)</IN><LP>   NEW YORK -- Over-the-counter stocks staged a feeble rallyon a late-afternoon Egyptian report of a growing movement inIraq to overthrow Saddam Hussein.   The Nasdaq Composite Index edged up 0.83 to 380.32, a 0.2%gain, after showing a slight loss most of the day. Volumeremained light at 98.5 million shares, down from 100.1million shares Tuesday. Advancing stocks narrowly outpaceddecliners, 890 to 809.</LP><TEXT>   &quot;The market's dull, choppy, and everybody's just watchingthe news,&quot; said Jim O'Neill, co-manager of OTC trading forRobinson-Humphrey Co. Mr. O'Neill agreed with other tradersthat some investors took heart from an Egyptian news reportof growing Iraqi opposition to Saddam Hussein.   Large, institutional investors continue to be selective,while small investors are largely inactive, said JamesTarantino, head of OTC trading at Hambrecht andamp; Quist in SanFrancisco. &quot;It's extremely, extremely slow,&quot; he added.   Some familiar OTC leaders regained favor as Nike sprinted2 to 73 and Amgen rose 1 7/8 to 48. Both companies werescheduled to appear yesterday at the final day of aMontgomery Securities conference in San Francisco.   Shortly before the market closed, Oppenheimer andamp; Co.biotechnology analyst Jeffrey Casdin repeated a &quot;buy&quot; opinionon Amgen, a biotechnology company based in Thousand Oaks,Calif. Mr. Casdin said in an interview he has a &quot;high degreeof confidence&quot; that a Food and Drug Administration advisorypanel will convene Dec. 13 and 14 to review Amgen's G-CSFproduct, which stimulates the production of white blood cellsto fight infection.   If the panel recommends approval of the product, then itcould be marketed next year, he said. Mr. Casdin also said hethinks Amgen's recent investment in a company that developsproducts to treat neurological disorders will help keep thestock trading at the current above-market multiple of itsearnings.   There were a few bright spots in the technology sector.Bullish analysts comments boosted Microsoft 1 7/8 to 57 3/8,while AST Research added 1 to 19 after a favorable meetingwith analysts in New York.   Lotus rebounded 1/2 to 17, after falling 1 1/2 Tuesdaywhen company officials said that growth will slow somewhat.Intel also rose 3/4 to 32 3/4 and was the day's most activestock.   Elsewhere in the technology group, Conner Peripherals fell1/4 to 22 1/4; Sun Microsytems eased 3/8 to 28 3/8; SeagateTechnology declined 1/4 to 8 1/2; Oracle Systems slipped 1/4to 8 1/4; and Apple Computer was unchanged at 34. The NasdaqIndustrial Index, which includes many large technologyshares, drifted most of the day but rallied at the close togain 1.66 to 406.45.   Microsoft was featured by Goldman Sachs analyst RickSherlund and Shearson Lehman Brothers analyst DavidReaderman, both of whom repeated their &quot;buy&quot; opinions on theRedmond, Wash., software maker. Mr. Sherlund said he expectsthat sales of Microsoft's highly successful Windows 3.0software this quarter could rapidly accelerate from the Junequarter, according to Dow Jones Professional Investor Report.   The analyst also raised his earnings estimate forMicrosoft's first quarter ending Sept. 30 to a range of 70cents to 75 cents a share from his previous estimate of 63cents. A year earlier Microsoft had profit of 43 cents ashare.   Microsoft's new local area network product, called LANManager, and network database product, SQL Server, arecritical to Shearson Lehman Brothers' estimated 30% to 35%near-term growth rate for the company, Mr. Readerman toldDJPIR. LAN Manager will help Microsoft capture a share of theapproximately $1 billion personal computer networking market,he said, adding that initial signs indicate the company ishaving some success in capturing some market share fromNovell.   Autodesk eased 1/2 to 46 1/2 after tumbling as low as 441/2. Traders attributed the fall to the resignation last weekof the company's vice president of software development,Ronald McElhaney, and rumors that his departure could delaythe introduction of Release 11.2, the company's newcomputer-aided design and drafting software product, DJPIRreported. However, Autodesk's chief financial officer,Carolyn V. Aver, said Mr. McElhaney's departure won't haveany impact on the product's release, which is expected inOctober.   TW Holdings was unchanged at 4 1/16 after slipping to 4earlier in the day. The Spartanburg, S.C., provider of food,vending and medical services said it is making twoprepayments totaling $70 million on senior debt out ofcurrent cash flow. Last month, TW Holdings led OTC stockswith the largest increase in short interest; the shortposition in the company rose more than one million shares, tonearly 2.2 million. Short-sellers borrow stock and sell it,hoping to profit by returning cheaper shares to the lender.Short interest is the total amount of shares sold short at agiven time.   Among the day's gainers, AEL Industries Class A sharesjumped 7/8 to 5 3/4. Tuesday afternoon, the Lansdale, Pa.,defense electronics concern reported that operating profitfor the second quarter ended Aug. 31 was 15 cents a share,compared with a year-earlier loss of $1.28 a share after an$8 million special provision.   Data Switch added 1/2 to 3 7/8. The Shelton, Conn., makerof switching products told investors in a news release thatInternational Business Machines's introduction last week ofswitching components expands Data Switch's marketopportunities.   Alliant Computer Systems gained 1/4 to 2 3/4. Tuesday, theLittleton, Mass., computer maker told investors in a newsrelease that it developed a new way for users in a DigitalVAX local area network to access an Alliant supercomputer.   United Artists Entertainment Class A shares jumped 1 1/8to 13. Officials with the Denver operator of cable televisionstations and theaters met with with analysts Tuesday morningand discussed a recent refinancng and its cable ventures inthe United Kingdom, DJPIR said.   Smith Barney, Harris Upham andamp; Co. analyst John Reidy toldDJPIR the refinancing now enables United Artists to borrow upto $500 million with little difficulty. Mr. Reidy, who ratesthe stock a &quot;buy,&quot; said there was also enthusiasm at themeeting for the company's British cable ventures and theprospects for its cash-flow growth.   First Executive Series F preferred shares tumbled 1 5/8 to3 3/4. Last month, the troubled Los Angeles insurer said itwas considering halting dividend payments on all of itspreferred stock.   ---   Phillip E. Nalbone contributed to this column.</TEXT></DOC>